Fluxion Biosciences

What Fluxion Biosciences does

Fluxion Biosciences is a privately held life-sciences tools company founded in 2005 and headquartered in Alameda, California, with 11–50 employees. The firm develops cellular analysis tools and drug discovery applications, and its commercial evidence indicates a portfolio of integrated instruments for cell engineering, culture, and analysis. The core product line spans the CellRaft AIR System for single-cell isolation and monoclonal clone generation (built around proprietary microscale polystyrene arrays that maintain cells in an unperturbed state and enable integrated imaging for clonality tracking), the BioFlux shear-flow system for physiological flow conditions, the CERO 3D incubator/bioreactor for organoid and spheroid culture, the CASY dye-free cell counter, the TIGR tissue dissociator, and the IonFlux Mercury automated patch clamp platform for ion channel research.

Name

Fluxion Biosciences

Website

https://fluxionbio.com

Company type

Private

Founded year

2005

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Life Sciences Laboratory Instruments

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Apparatus & Furniture (3821)

akta.pro primary industry

General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens) (HLAGAIAC)

akta.pro secondary industry

Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG)

Keywords

• Cellular analysis instruments
• Single cell isolation
• Drug discovery platforms
• Electrophysiology systems
• Lab automation equipment

Headquarters

HQ city

Alameda

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Laboratory Instruments and Systems: Sale of capital equipment including CellRaft AIR System, BioFlux, CERO 3D, CASY Cell Counter, TIGR, and IonFlux systems. Instruments are sold directly and through distributors globally.
2. Consumables and Arrays: Ongoing revenue from consumables including CellRaft Arrays and other single-use laboratory supplies required for instrument operation.
3. Lab Services: Custom services for cell line and custom organoid development offered through expanded lab services.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Fluxion Biosciences develops and manufactures integrated laboratory instruments and consumables for cellular analysis, cell line development, and drug discovery. Its portfolio includes the BioFlux shear flow system, IonFlux Mercury automated patch clamp platform, CASY cell counter/analyzer, CERO 3D incubator and bioreactor, TIGR tissue dissociator, and the CellRaft AIR single-cell isolation system. The instruments are sold direct and through global distributors to academic, pharmaceutical, and biotechnology research laboratories.

Product overview

Cell Microsystems offers an integrated platform of cell engineering, culture, and analysis products. The core portfolio includes the CellRaft AIR System for single cell isolation and clone generation, the CASY Cell Counter & Analyzer for automated cell counting, the BioFlux Shear Flow System for physiological flow conditions, the CERO 3D Incubator & Bioreactor for 3D cell culture, the TIGR Tissue Grinder and Dissociator for tissue processing, and the IonFlux Mercury for automated patch clamp electrophysiology. These products work together to support 2D and 3D cell engineering, cell analysis, microbiology research, and ion channel studies.

Differentiator

Problem solved

Functional benefit

Products and services

• BioFlux System Shear flow system that introduces physiological shear flow conditions (0–200 dyn/cm²) to research and drug discovery experiments, emulating in vivo conditions, with up to 96 parallel flow cell assays for applications in microbiology, hematology, vascular biology, and oncology.
• IonFlux Mercury Automated patch clamp electrophysiology system offering scalable recordings with 16 to 256 parallel channels, well-plate simplicity, fast liquid exchange, and temperature control up to 40°C, designed for ion channel screening and drug discovery in cardiovascular, CNS, and other indications.
• CASY Cell Counter & Analyzer Automated cell counting and analysis instrument that provides precise cell counts and viability assessments across a wide sample range (large stem cell aggregates to small yeast or bacteria) without the need for dyes or reagents, preserving sample integrity and reducing consumable costs.
• CERO 3D Incubator & Bioreactor 3D cell culture technology that monitors and controls temperature, pH, and CO₂ levels to create an optimal environment for organoid, spheroid, stem cell, and tissue research.
• TIGR Tissue Grinder and Dissociator Semi-automated tissue dissociation system using gentle mechanical dissociation to yield high quality single cells 5–15x faster than enzymatic dissociation, processing 4 individual samples in parallel for single-cell genomics and downstream assays.
• CellRaft AIR System Single cell isolation and clone generation system that uses proprietary microscale polystyrene CellRaft arrays to spatially segregate cells and colonies while maintaining shared media access, providing 10–50x more viable monoclonal colonies compared to limiting dilution and FACS, with integrated imaging to track and verify monoclonality.
• Lab Services Custom services for cell line development and custom organoid development provided by Fluxion Biosciences' lab services team to support customer research and drug discovery workflows.

Quantifiable outcome

• 5-fold increase in clones obtained compared to current methods
• +6 more outcomes

Named customers29 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Becton, Dickinson and Company (BD): BD's FACS instruments and cell-sorting portfolio directly compete with CellRaft AIR for single-cell isolation workflows in academic and pharma labs, and BD's installed base dwarfs Fluxion's. It is the most cited incumbent alternative to the CellRaft platform.
• Thermo Fisher Scientific: Provides a broad portfolio of cell analysis, cell culture, and lab instruments (flow cytometry, cell counters, bioreactors) that overlaps with multiple Fluxion product lines including CASY, CERO 3D, and BioFlux. Scale, distribution, and bundling make it the dominant comparator.
• Sartorius: Strong in cell line development and bioprocess equipment (e.g., ambr systems, bioreactors, cell counters), directly comparable to Fluxion's CERO 3D and CASY offerings, particularly for cell therapy and biopharma process development customers.
• Beckman Coulter Life Sciences (Danaher): Offers flow cytometry, cell counting (Vi-Cell), and lab automation that overlap with CASY cell counting and shear-flow/analytical use cases; backed by Danaher's scale and global service network.
• Bio-Techne (R&D Systems): Supplies reagents, cell culture media, and increasingly instruments for cell and gene therapy workflows, competing with Fluxion's reagents-adjacent consumables and broader cell line development offering.

Direct peers

• 10x Genomics: Single-cell genomics and cell preparation platforms (Chromium, etc.) target overlapping academic and pharma researchers preparing single cells for downstream assays; their workflow competes for budget allocation alongside TIGR and CellRaft.
• Molecular Devices (Danaher): Makes automated patch clamp and electrophysiology systems (e.g., IonWorks) that directly compete with the IonFlux Mercury platform in ion channel screening for pharma drug discovery.
• Nanion Technologies: Specializes in automated patch clamp (Patchliner, SyncroPatch) and bilayer electrophysiology, directly competing with IonFlux Mercury for ion channel drug discovery throughput and cost-per-data-point positioning.

Emerging players

• Cytek Biosciences: Flow cytometry and spectral cell analysis platforms aimed at academic and biotech researchers; competes for the same lab budget as BioFlux and IonFlux, particularly in immunology and cell biology applications.
• CellGenix: Cell and gene therapy raw materials and process development tools, overlapping with Fluxion's cell line development and cell therapy customer base (e.g., Kite Pharma).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/fluxionbio
• Facebookfacebook.com/2706284048
• LinkedInlinkedin.com/company/fluxion-biosciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds5 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fluxion Biosciences